News
‘Substantial’ variation in responses to BP meds
A new study shows significant variation in the blood pressure response to various antihypertensive medications between individuals.
News
Antiphospholipid antibodies linked to future CV events
The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular...
News
Specific brain damage links hypertension to cognitive impairment
Researchers have identified specific regions of the brain that appear to be damaged by high blood pressure; the finding may explain the link...
News
Does new heart transplant method challenge definition of death?
Heart donation after circulatory rather than brain death increases donor hearts available to save lives, but the processes involved raise ethical...
News
Oral PCSK9 inhibitor shows encouraging LDL lowering
A new oral formulation of a PCSK9-inhibiting cholesterol-lowering drug has shown encouraging results in a phase 2 study.
News
Endurance exercise tied to more coronary atherosclerosis
Lifelong endurance athletes had more coronary plaques, including more noncalcified plaques, than fit and healthy individuals, according to a new...
News
Encouraging 3-year data for TAVR in low-risk patients: EVOLUT
The 3-year results show that low-surgical-risk patients undergoing aortic valve replacement continue to show lower rates of all-cause mortality...
News
‘Keto-like’ diet linked to doubling of heart disease risk
But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.
News
BIOVASC: Immediate complete revascularization beneficial in ACS
Immediate complete revascularization during the index procedure might become the new treatment paradigm in patients with ACS and multivessel...
News
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
News
New AHA statement urges focus on CV risk before pregnancy
The emphasis on reducing cardiovascular risk during pregnancy comes too late – the risks have already developed in these patients.
News
Similar effect of early, late BP reduction in stroke: CATIS-2
“Antihypertensive treatment can be delayed for at least 7 days following ischemic stroke onset, unless there are severe acute comorbidities that...
News
Thrombolysis not necessary in mild nondisabling stroke: ARAMIS
‘We may be doing more harm than good with alteplase in this patient population,’ says expert.
News
Drug combo promising in vascular cognitive impairment: LACI-2 trial results
The drugs – isosorbide monoitrate and cilostazol – stabilize endothelial function, which is a new therapeutic target for patients with small-...
News
Thrombectomy benefits stroke with large core volumes: SELECT2 trial results
Study findings may change clinical practice and the way in which systems of stroke care are organized.